CASI Pharmaceuticals, Inc.(CASIF)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

CASI Pharmaceuticals, Inc. (CASIF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CASIF is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $43.1m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), CASI Pharmaceuticals, Inc. reports quarterly revenue of $20.7M, net income of $-48.1M, free cash flow of $-20.8M. CASIF trades on the Nasdaq exchange and files with the SEC under CIK 1962738. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CASIF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CASI Pharmaceuticals, Inc. directly from SEC EDGAR.

Revenue

$20.7M

Net Income

$-48.1M

Free Cash Flow

$-20.8M

CASIF key financials by period

CASI Pharmaceuticals, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202520-F$20.7M$-48.1M—
FY 202420-F$28.5M$-39.3M-138.8%
FY 202320-F$33.9M$-27.0M-74.0%
FY 202220-F$43.1M$-41.0M-79.0%
FY 202120-F$30.2M$-36.7M-137.6%
FY 202020-F$15.1M$-48.3M—

Institutions holding CASIF

Institutional investors reporting a position in CASI Pharmaceuticals, Inc. on SEC Form 13F.
InstitutionSharesValueReported
WEST PACES ADVISORS100$17.002026-06-30
SEC EDGAR: CIK 1962738 →
CASIF

CASI Pharmaceuticals, Inc.

CASIF
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $43.1M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

FY 2025
EDGAR

$20.71M

Net Income

FY 2025
EDGAR

$-48.06M

EPS (Diluted)

FY 2025
EDGAR

$-2.59

Free Cash Flow

FY 2025
EDGAR

$-20.77M

Top Institutional Holders

as of Q2 2026
$17 total
WEST PACES ADVISORS INC.
$17New
Loading ratio trend…